Search Results
Jul 21, 2026, 08:01 ET DM Injury Law Wins Gold for Customer Service in Kansas City Star Favorites Awards
2026 /PRNewswire/ -- When people think about lawyers, "great customer service" isn't always the first thing that comes to mind. That's why DM Injury Law is especially proud to announce it has been named the Gold Winner for Best Customer Service in the 2026 Kansas City Favorites Awards, from
More news about: DM Injury Law
Jul 17, 2026, 13:30 ET FTX Announces Fifth Distribution of Approximately $900 Million to Creditors on July 31, 2026
https://cases.ra.kroll.com/FTX/.FTX Digital Markets Ltd. ("FTX DM") will be separately communicating distribution information for customers who have elected to have their claims administered by FTX DM.AdvisorsFTX is represented by Sullivan & Cromwell LLP as
More news about: FTX
Jul 16, 2026, 09:46 ET SOUEAST lleva la pasión del fútbol a cuatro mercados latinoamericanos
siete países de América Latina, construyendo una red local de ventas y servicios establecida. Su línea de productos incluye los modelos S06, S06 DM, S07, S08 DM y S09, que ofrecen modelos híbridos y con motor de combustible para satisfacer las diversas necesidades de los clientes.La campaña de fútbol
More news about: SOUEAST
Jul 15, 2026, 09:15 ET DM Injury Law Earns Two Best Law Firm Honors in Kansas City Community Awards
KANSAS CITY, Mo., July 15, 2026 /PRNewswire/ -- DM Injury Law is proud to announce it has been recognized with two of Kansas City's top community-voted honors, reinforcing the firm's reputation as one of the region's leading
More news about: DM Injury Law
Jul 15, 2026, 01:47 ET StarLovin Highlights Email Capture and Contacts for Instagram DM and Facebook Messenger Automation
/PRNewswire/ -- StarLovin, a Meta-approved creator growth automation platform, recently highlighted email capture and Contacts features for its Instagram DM and Facebook Messenger automation workflows. The update helps creators, media operators, coaches, and small businesses respond faster, collect emails
More news about: Starlovin
Jul 13, 2026, 13:18 ET KFC® Answers Fans' Calls (and Comments) With the Return of Popcorn Chicken, Reigniting Obsession Nationwide
Chicken obsession once again."For years, KFC has heard directly from fans clamoring for Popcorn Chicken's return. We read every comment, every DM, and even every online petition signature, and the message was impossible to ignore," said Melissa Cash, Chief Marketing Officer, KFC U.S. "As
More news about: Kentucky Fried Chicken
Jul 13, 2026, 07:30 ET Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research
polymyositis (DM/PM) are rare inflammatory diseases that cause progressive muscle weakness,4 with the former also causing characteristic skin rashes and the latter primarily affecting the muscles closest to the trunk of the body.5 People of all ages can be affected, though DM and PM most
More news about: Keenova Therapeutics
Jul 08, 2026, 14:23 ET /C O R R E C T I O N -- DM Vans/
In the news release, DM Vans Sells Out Its Entire 2026 Model Year Ahead of Schedule as the RV Industry Posts Steepest Declines in Recent Memory, issued 07-Jul-2026 by DM Vans over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with
More news about: DM Vans
Jul 08, 2026, 09:04 ET Eligible Original Medicare patients can now access Nerva's gut-brain therapy program at no out-of-pocket cost
1. Brain-gut behavior therapy is recommended for IBS in the ACG Clinical Guideline. Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021.
More news about: Mindset Health
Jul 06, 2026, 17:49 ET AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada
treatment options remains critical, and we look forward to updating on our progress in advancing this program in the months ahead."Congenital DM1 is a rare, inherited neuromuscular disorder that can cause serious and lifelong challenges affecting muscle function, learning difficulties, development,
More news about: AMO Pharma Limited
Jul 06, 2026, 17:30 ET AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada
treatment options remains critical, and we look forward to updating on our progress in advancing this program in the months ahead."Congenital DM1 is a rare, inherited neuromuscular disorder that can cause serious and lifelong challenges affecting muscle function, learning difficulties, development,
More news about: AMO Pharma Limited
Jul 06, 2026, 09:00 ET KAYALI Launches Boujee Kitty Caramel Milk | 22 Eau de Parfum, a New Gourmand Fragrance Created by Mona Kattan
$10510ml DM$32
More news about: KAYALI
Jun 25, 2026, 04:35 ET StarLovin Launches Automated Instagram DM Features for Creators
platform.Collect Emails Directly Inside DMsStarLovin's email collection feature allows creators to request an email address directly inside an Instagram DM before delivering a link, freebie, guide, offer, or download. Once a follower enters their email, StarLovin checks that it is in a valid email format,
More news about: Starlovin
Jun 23, 2026, 08:49 ET D&M Leasing Marks 50 Years as the Nation's Largest Consumer Car Leasing Company
multimedia:https://www.prnewswire.com/news-releases/dm-leasing-marks-50-years-as-the-nations-largest-consumer-car-leasing-company-302807405.htmlSOURCE
More news about: D&M Leasing
Jun 20, 2026, 08:00 ET New white paper on closing the AI fluency gap to support workforce retention published by the University of Phoenix College of Doctoral Studies
Studies has published a new white paper, "The Retention Mandate: Bridging the AI Fluency Gap to Secure the 2026 Workforce," authored by Wayne L. McCoy, DM, MBA, and released through the
More news about: University of Phoenix
Jun 18, 2026, 01:02 ET MAXHUB Showcases AI-Powered Collaboration and Display Solutions at InfoComm 2026
platform for centralized device and content management, and an expanded Microsoft Teams Rooms portfolio featuring the Scheduling Panel SP10, Mic Pod DM30, and Universal Console TCP33T.Further underscoring MAXHUB's commitment to innovation, the MAXHUB XBar W70 Kit was recognized with the SCN Installation
More news about: MAXHUB
Jun 12, 2026, 08:00 ET Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bofanglutide Meets Primary Endpoints in Phase III Weight Loss Study in China and Phase II Study in the U.S.
clinical trial conducted at 80 medical sites across China (ClinicalTrials.gov Identifier: NCT06767761). The study enrolled 596 adults with type 2 diabetes (T2DM) who had previously been treated with basal-bolus insulin, premixed insulin analogs or dual insulin analog. It evaluated once-weekly Insulin Ludefen
More news about: Gan & Lee Pharmaceuticals
Jun 08, 2026, 08:31 ET MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
improved glucose control. Furthermore, in Phase 1a and 1b trials, vanoglipel was well tolerated in both healthy volunteers and those with T2DM. In a Phase 2a clinical study, vanoglipel demonstrated direct hepatic action in addition to its glucose lowering effects.About
More news about: MetaVia Inc.
Jun 06, 2026, 14:54 ET University of Phoenix researchers publish study examining doctoral students' attitudes toward AI chatbots and ChatGPT use in higher education
learning, and research practices in digital learning environments. The authors of this study include Suchitra Veera, DBA, Anthony Bennett, DM and James Rice, DM/IST, and participate in CEITR's
More news about: University of Phoenix
Jun 05, 2026, 19:30 ET Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
2321-P - Machine-Learning Modeling for T2DM Prediction in over 3 Million Adults [Board No. 2321]Luis A. Rodriguez, PhD, MPH, RDGeneral poster sessionSaturday,
More news about: American Diabetes Association
Jun 03, 2026, 18:01 ET ERA Congress: Semaglutida ligada a melhor qualidade de vida em diabetes e doença renal, mostra teste DE FLUXO
ERA, mostram que a semaglutida uma vez por semana melhorou significativamente a qualidade de vida relacionada à saúde em adultos com diabetes tipo 2 (dm2) e doença renal crônica (DRC), o equivalente a cerca de oito dias adicionais em plena saúde por ano. O estudo demonstrou anteriormente que
More news about: ERA Congress
Jun 03, 2026, 11:00 ET AI Is Rewriting Affiliate Marketing
Ronn Torossian, Founder, 5W. "You cannot cold-recruit the editor at a top beauty publication. You cannot DM your way into a partnership with a creator whose audience took ten years to build. Those partners have more requests than they can fulfill. They have
More news about: 5W Public Relations
Jun 03, 2026, 06:00 ET Malwarebytes Launches Free Reverse Phone Check to Help Consumers Identify Potential Scam Numbers
Guard: Scam detector combining the ease of an AI chat bot with the company's deep threat intelligence expertise to check a suspicious text, link, DM or message alongside actionable guidance on what to do next.To explore all free options, visit:
More news about: Malwarebytes
Jun 01, 2026, 03:04 ET China's Original Innovative Drug Cipepofol Approved for Marketing by the U.S. FDA
elderly patients undergoing major noncardiac surgery: A randomised controlled pilot trial. Eur J Anaesthesiol. 2022;6.8(IF).Liu YJ, Yu XY, Zhu DM, et al. Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label,
More news about: Haisco
May 28, 2026, 11:23 ET PressLogic 推出 ChatBooster 免費方案及在地化廣東話 AI Agent 逆市為香港中小企與創作者注入強大增長動力
AI，極速降低管理開支。本地通訊渠道 24/7 秒回： 香港消費者習慣在 WhatsApp 和 IG 要求即時回覆。AI Agent能全天候無間斷處理海量查詢，無需增加任何額外人手。引爆社交電商轉化率： 將社交媒體上的 casual DM 自動化轉化為真正訂單。AI Agent能透過智能、在地化的對話實時引導銷售，牢牢抓緊顧客的專注度。此次 ChatBooster 免費方案的推出，標誌著香港創科生態逐步由「概念炒作」走向「真正落地」—— 讓 AI 轉化為人人可用、真正幫到手的 SaaS 基礎設施，與香港企業共渡時艱。ChatBooster
More news about: PressLogic